W.M. Drake
Osteoporosis Research Center
University of British Columbia
Vancouver
Canada
Name/email consistency: high
- Use of phalangeal bone mineral density and multi-site speed of sound conduction to monitor therapy with alendronate in postmenopausal women. Drake, W.M., Brown, J.P., Banville, C., Kendler, D.L. Osteoporos. Int (2002)
- Optimizing gh therapy in adults and children. Drake, W.M., Howell, S.J., Monson, J.P., Shalet, S.M. Endocr. Rev. (2001)
- Desensitization of CGRP and adrenomedullin receptors in SK-N-MC cells: implications for the RAMP hypothesis. Drake, W.M., Ajayi, A., Lowe, S.R., Mirtella, A., Bartlett, T.J., Clark, A.J. Endocrinology (1999)
- Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis. Drake, W.M., Perry, L.A., Hinds, C.J., Lowe, D.G., Reznek, R.H., Besser, G.M. J. Clin. Endocrinol. Metab. (1998)